Kovina Therapeutics
Pre-clinicalKovina therapeutics is a preclinical stage biotechnology company developing targeted antiviral therapeutics designed to eliminate HPV-driven cancers and prevent the progression of premalignant infections caused by Human Papillomavirus (HPV).
Founded
2021
Focus
Small Molecules
About
Kovina therapeutics is a preclinical stage biotechnology company developing targeted antiviral therapeutics designed to eliminate HPV-driven cancers and prevent the progression of premalignant infections caused by Human Papillomavirus (HPV).
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile